Loss Of Walking Ability - Articles

Sort by: Newest Most Comments Relevance

New drug could improve walking ability of people with multiple sclerosis by Jeff Pile

People's HealthBlogger Awards 2009 - Best 100 Winner!

Posted Sat 06 Mar 2010 5:30am NAPLES — Jeff Cooperstein is waiting for his Naples pharmacy to get a new drug for multiple sclerosis that can improve walking ability of people with the disease. He fully expects a battle with his insurance carrier over the cost of the drug, Ampyra, which will run him $600 a month. “It is kind of my forte now,” the 54-year-old retire ... Read on »

Experimental Drug for MS helps to improve walking ability for some by stuart Patient Expert

Posted Tue 17 Nov 2009 10:20pm AFP PARIS (AFP) An experimental drug called fampridine improves walking ability in some patients with multiple sclerosis (MS), a disease of the nervous system that crimps mobility, a study published on Friday in The Lancet says. Doctors recruited 301 adults with MS in the United States and Canada, and gave the drug to 229 of the recru ... Read on »

are frustrated with Fisher's ability to walk a defender by uiawseaw Posted Wed 23 Jan 2013 3:41am 400 yards and 24 touchdowns with 16 interceptions this season. He ranked 17th with an 83.3 passer-rating and struggled to hit downfield hnson which will go a long way in helping him get noticed by NFL clubs. He already has a good reputation as a rusher. "He does a really nice job of using his hands and his feet to block, and is one of 17 finalis ... Read on »

Patient’s Own Stem Cells Gives Her Relief to Help Heal Faster And The the Ability To Walk Pain Free After Back Surgery by Medical Quack Patient Expert

Posted Tue 21 Sep 2010 3:58pm The device used here looks like the Cytori machine that I have covered before here that cleans and harvests stem cells. Her quality of life has improved and there’s no problem with rejection since it is her own cells and she is back to walking again. This is amazing. Her cells were re-injected at the surgery site to help her heal. I ... Read on »

Fampridine-SR (4-aminopyridine) is a new drug in development to help improve walking ability in people with multiple sclerosis by stuart Patient Expert

Posted Mon 30 Mar 2009 4:26pm Fampridine-SR ("4-aminopyridine", "4-AP", “fampridine”) is an investigational oral, sustained-release tablet formulation of 4-aminopyridine. In laboratory studies fampridine has been found to improve impulse conduction in nerve fibers in which the insulating layer, called myelin, has been damaged. Clinical History of Fampridine-SR i ... Read on »

A major unmet need in the treatment of Multiple Sclerosis is a medication to increase walking ability. by stuart Patient Expert

Posted Tue 17 Nov 2009 10:20pm A major unmet need in the treatment of Multiple Sclerosis is a medication to increase walking ability. Since disease modifying therapies have only been available for 16 years, MS starts at a mean age of 29, and the disease has only a minimal effect at shortening lifespan, the majority of MS patients presently have progressive forms of MS. Ten ... Read on »

Biogen Idec Submits Application In Europe For The Approval Of Fampridine-PR Tablets To Improve Walking Ability In People With Mu by stuart Patient Expert

Posted Wed 13 Jan 2010 12:00am Biogen Idec (NASDAQ: BIIB) announced the submission of a marketing authorization application (MAA) to the European Medicines Agency for Fampridine Prolonged Release (Fampridine-PR) tablets, a novel oral therapy for the improvement of walking ability in adult patients with multiple sclerosis(MS). The company also has filed a New Drug Submission ... Read on »

News Release: Acorda Therapeutics Reports Date of FDA Advisory Committee Review of Fampridine-SR for Improvement of Walking Abil by stuart Patient Expert

Posted Tue 17 Nov 2009 10:20pm Peripheral and Central Nervous System Drugs Advisory Committee to Hold Meeting on October 14, 2009 Proposed Trade Name for Fampridine-SR, if approved, is Amaya™ HAWTHORNE, N.Y. --(BUSINESS WIRE)--Aug. 25, 2009-- Acorda Therapeutics, Inc.(Nasdaq: ACOR ) today announced that the U.S. Food and Drug Administration ( FDA ) has co ... Read on »

Acorda Therapeutics Submits New Drug Application for Fampridine-SR for Improvement of Walking Ability in People with Multiple Sc by stuart Patient Expert

Posted Tue 17 Nov 2009 10:20pm Drugs.com New Drug Application (NDA) Submitted for Fampridine-SR ( 4-aminopyridine [4AP] ) HAWTHORNE, N.Y.--(BUSINESS WIRE)--Feb 2, 2009 - Acorda Therapeutics, Inc. (Nasdaq: ACOR) today announced the submission of a New Drug Application to the U.S. Food and Drug Administration (FDA) on January 30, 2009 for Fampridine-SR, a novel the ... Read on »

Fampridine-SR Update - for the proposed indication of improvement of walking ability in people with multiple sclerosis (MS). by stuart Patient Expert

Posted Tue 17 Nov 2009 10:20pm Acorda Therapeutics Announces Posting of Briefing Documents for October 14 FDA Advisory Committee Meeting on Fampridine-SR Company to Host Investor Conference Call onThursday, October 15at8:00 a.m. HAWTHORNE, N.Y.--(BUSINESS WIRE)--Oct. 9, 2009--Acorda Therapeutics, Inc.today announced that theU.S. Food and Drug Admini ... Read on »